Scilex Holding, a Subsidiary of Sorrento Therapeutics, Announces Phase 2 Trial Results for its Leading SP-102 Program

NEXT STORY
Genmab Announces Submission of Supplemental Biologics License Application to FDA for Daratumumab in Combination with Bortezomib, Thalidomide and Dexamethasone in Frontline Multiple Myeloma
PREV STORY
Global Capillary Blood Collection Devices Market, 2017-2018 & 2025: Increasing Incidence of Chronic, Infectious and Autoimmune Diseases Propelling Market Growth
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Midatech Pharma Plc: Trading update

  14 February 2018Midatech Pharma PLC("Midatech", "Company" or "Group") Trading update Midatech (AIM: MTPH, ...

author_avatar
NASDAQ Market News

Onconova Therapeutics Regains Rigosertib Rights in Greater China

author_avatar
NASDAQ Market News

BeyondSpring Announces Submission of New Drug Application to U.S. FDA and China NMPA for Plinabulin and G-CSF Combination for the Prevention of Chemotherapy-Induced Neutropenia (CIN)

author_avatar
NASDAQ Market News